Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease
Abstract Background C-type natriuretic peptide (CNP) is a member of the natriuretic peptide family and have been implicated to be involved in maintaining vascular homeostasis and acting as a cardiac chronotropic agent in experimental studies. However, clinical evidence of its participation in cardio...
Main Authors: | Lulu Wang, Wenjin Liu, Yanting Yu, Lei Jiang, Junwei Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-0843-3 |
Similar Items
-
Natriuretic peptide system and cardiovascular disease
by: Federico Cacciapuoti
Published: (2010-01-01) -
The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
by: Hidetaka Hamasaki
Published: (2016-05-01) -
Clinical value of natriuretic peptides in chronic kidney disease
by: Carla Santos-Araújo, et al.
Published: (2015-05-01) -
Clinical value of natriuretic peptides in chronic kidney disease
by: Carla Santos-Araújo, et al.
Published: (2015-05-01) -
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
by: A A Pulin, et al.
Published: (2014-01-01)